Brief: Phathom Pharmaceuticals Provides Update On New Drug Application

Phathom Pharmaceuticals

03/01/2023 21:28

Jan 3 (Reuters) - Phathom Pharmaceuticals Inc  PHAT.O :
    * PHATHOM PHARMACEUTICALS PROVIDES UPDATE ON NEW DRUG
APPLICATION
REVIEW OF VONOPRAZAN FOR EROSIVE ESOPHAGITIS
    * PHATHOM PHARMACEUTICALS INC - U.S. FDA HAS NOTIFIED
COMPANY THAT
NO ACTION WILL BE TAKEN ON COMPANY'S NEW DRUG APPLICATION (NDA)
FOR VONOPRAZAN
    * PHATHOM PHARMACEUTICALS INC - CO NO LONGER EXPECTS PRODUCT
LAUNCHES FOR H. PYLORI OR EROSIVE ESOPHAGITIS IN Q1 OF 2023
    * PHATHOM PHARMACEUTICALS INC - EXPECT TO UPDATE ANTICIPATED
LAUNCH TIMING AFTER GAINING FURTHER CLARITY ON STABILITY
REQUIREMENTS FROM FDA

Source text for Eikon:  ID:nGNX4S1Gh0 
Further company coverage:  PHAT.O 
 ((Reuters.Briefs@thomsonreuters.com;))